| Piramal Life Sciences has reported a sales turnover of Rs 13.98 crore and a net loss of Rs 25.68 crore for the quarter ended Dec '10. | | For the quarter ended Dec 2009 the sales turnover was Rs 1.22 crore and net loss was Rs 36.76 crore. |
|
| | Quarterly Results of Piramal Life Sciences | -------- in Rs. Cr. -------- |
|
| Dec '09 | | | Sep '10 | Dec '10 | | Sales Turnover | 1.22 | | | 0.83 | 13.98 | | Other Income | -- | | | -- | -- | | Total Income | 1.22 | | | 0.83 | 13.98 | | Total Expenses | 28.28 | | | 28.69 | 26.30 | | Operating Profit | -27.06 | | | -27.86 | -12.32 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | -27.06 | | | -27.86 | -12.32 | | Interest | 6.98 | | | 8.78 | 10.46 | | PBDT | -34.04 | | | -36.64 | -22.78 | | Depreciation | 2.72 | | | 2.83 | 2.90 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | -36.76 | | | -39.47 | -25.68 | | Tax | -- | | | -- | -- | | Net Profit | -36.76 | | | -39.47 | -25.68 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | -- | | | -- | -- | | Book Value | -- | | | -- | -- | | Equity | 25.45 | | | 25.45 | 25.45 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
